We are live on
!
Find out more
SC
Slotnik Capital Portfolio holdings
AUM
$342M
1-Year Est. Return
105.92%
This Fund
S&P 500
This Quarter
Est. Return
+31.17%
1 Year Est. Return
+105.92%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$429M
AUM Growth
+$109M
(+34%)
Cap. Flow
+$82.3M
Cap. Flow
% of AUM
19.17%
Top 10 Holdings %
Top 10 Hldgs %
62.76%
Holding
49
New
22
Increased
3
Reduced
6
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RNAM
Avidity Biosciences
RNAM
|
+$46.2M |
| 2 |
EXAS
Exact Sciences
EXAS
|
+$25.7M |
| 3 |
CMA
Comerica
CMA
|
+$21.4M |
| 4 |
GTLS
Chart Industries
GTLS
|
+$21.2M |
| 5 |
Warner Bros
WBD
|
+$16.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Electronic Arts
EA
|
+$28.3M |
| 2 |
VRNA
Verona Pharma
VRNA
|
+$18.2M |
| 3 |
ARIS
Aris Water Solutions
ARIS
|
+$17.3M |
| 4 |
STAAR Surgical
STAA
|
+$17.1M |
| 5 |
Norfolk Southern
NSC
|
+$14.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 24.51% |
| 2 | Healthcare | 23.88% |
| 3 | Technology | 11.26% |
| 4 | Financials | 9.67% |
| 5 | Industrials | 8.38% |
Similar funds
YCM
WPA
RW
SW
FCM
VRM
CWA
VST
Slotnik Capital's Q4 2025 Portfolio in Review
As of Q4 2025, Slotnik Capital held 49 positions worth $429M, up 34% from $320M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Slotnik Capital deployed $82.3M of net new capital in Q4 2025, opening 22 new positions and adding to 3 existing holdings. Its largest new stake was Avidity Biosciences: 715,000 shares worth $51.6M.
By sector, the portfolio is most concentrated in Communication Services at 25% of assets, down from 42% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Electronic Arts, an estimated $28.3M trimmed.
- Slotnik Capital's largest Q4 2025 buy was Avidity Biosciences: 715,000 shares worth $51.6M.
- Slotnik Capital added most to Warner Bros in Q4 2025, an estimated $16.5M increase.
- Slotnik Capital's biggest Q4 2025 reduction was Electronic Arts, cutting an estimated $28.3M.
- Slotnik Capital fully exited Verona Pharma in Q4 2025, selling an estimated $18.2M.
- Slotnik Capital's ten largest holdings make up 63% of its $429M portfolio in Q4 2025.
- Slotnik Capital opened 22 new positions and closed 17 in Q4 2025.
- Slotnik Capital's portfolio value rose 34% quarter-over-quarter to $429M.
Based on Slotnik Capital's 13F filing for Q4 2025, filed 13 Feb 2026.